Emerging within the UK, retatrutide, a new compound , is creating considerable interest within the scientific community regarding its ability for physique management . This dual GIP and GLP-1 receptor agonist seems to provide a substantial improvement over existing therapies, showing encouraging results in early clinical assessments. Researchers th